Skip to main content
70°
Sunny
Site search
Search
Menu
Search
Subscribe
Open user controls
Log In Using Your Account
Log In
Don't have an account?
Sign Up Today
My Account
Dashboard
Profile
Saved items
Logout
Home
Contact Us
Subscribe
News
East Greenwich
Kent County Daily Times
Narragansett Times
NK Standard-Times
Sports
Features
Special Sections
Local Guide
Local Events
Markets & Stocks
Weather
League of Women Voters SRI
League of Women Voters WS
Classifieds
Place ad
Business Service Directory
Legal Notices
Place Kent Legal
Place SRI Class Legal
Search SRI Legals
Search Kent Legals
Obituaries
Subscribe
E-Edition
Community Choice
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries
Latest News about CYBN
Recent news which mentions CYBN
< Previous
1
2
3
4
5
6
7
8
9
...
17
18
Next >
Psyched: $100M For MDMA Therapy, VA Funds, 2024 Watchlist, Reform Updates And More
January 12, 2024
Tickers
ATAI
CMND
CMPS
CYBN
Tags
CMPS
Markets
GHRS
From
Benzinga
30 Psychedelics Executives, Scientists & Influencers To Watch In 2024 And Beyond
January 10, 2024
Tickers
CYBN
ENVB
NEWS
NUMIF
Tags
TRIL
Market News
News
From
Benzinga
Cybin Inc's Two Deuterated Psychedelic Molecules Achieve Positive Topline Clinical Results
January 09, 2024
Tickers
CYBN
NEWS
Tags
Management
News
Market News
From
Benzinga
Psychedelics Developer Secures $100M In Series A Funding, Will Support MDMA Approval To Treat PTSD
January 06, 2024
Tickers
ATAI
CMPS
CYBN
DMTTF
Tags
Joe Samberg
General
Market News
From
Benzinga
Psychedelic Stock Gainers And Losers From January 1, 2024
January 01, 2024
Tickers
ATAI
CMPS
CYBN
GHRS
Tags
Market News
Movers
ATAI
From
Benzinga
Mind-Bending Growth: 3 Psychedelic Stocks With Trippy Potential
December 14, 2023
Tickers
BIIB
CYBN
SUPN
Tags
SUPN
CYBN
NYSE:CYBN,NASDAQ:SUPN,NASDAQ:BIIB
From
InvestorPlace
Psyched: Defense Dept.'s Ketamine Trial, Cybin's Psilocybin, Metabolic Disorders, Reform Update And More
December 05, 2023
Tickers
ATAI
CMND
CMPS
CYBN
Tags
SILO
Ketamine Treatment
Market News
From
Benzinga
Cybin's Novel Psilocybin Topline Data: 79% Remission In Major Depression Symptoms, What's Next?
December 03, 2023
Tickers
CYBN
Tags
Market News
News
Next/Generation Psychedelics
From
Benzinga
Psyched: Ramaswamy Psychedelics For PTSD, UK Clinical Trials, Johns Hopkins Q&A And More
November 24, 2023
Tickers
ATAI
AWKNF
CMPS
CYBN
Tags
Cannabis
IXHL
Johns Hopkins Center for Psychedelic and Consciousness Research
From
Benzinga
GH Research, Compass Pathways Among Top Psychedelic Movers Of Today
November 23, 2023
Tickers
ATAI
CMPS
CYBN
GHRS
Tags
Market News
Movers
ATAI
From
Benzinga
Analyst Expectations for Cybin's Future
November 17, 2023
Tickers
CYBN
Tags
CYBN
Benzinga
Analyst Ratings
From
Benzinga
Expedia To Rally Around 54%? Here Are 10 Top Analyst Forecasts For Friday
November 17, 2023
Tickers
A
ADI
CMAX
CYBN
Tags
A
CYBN
Benzinga
From
Benzinga
Cybin Reports Access To $101M To Sustain Deuterated Psychedelics Programs, Q2 Numbers & 2024 Goals
November 15, 2023
Tickers
CYBN
Tags
Doug Drysdale
Market News
News
From
Benzinga
Psyched: Veterans & Psychedelics, $100M IPO, Cybin's $64M Offering, Worldwide Events & More
November 12, 2023
Tickers
ATAI
CMPS
CYBN
DRUG
Tags
ATAI
Cannabis
IXHL
From
Benzinga
Cybin Launches Five-Day Units Offering For Up To $64M, Suspends Prior LPC Funding Deal
November 10, 2023
Tickers
CYBN
Tags
Cannabis
Markets
Benzinga
From
Benzinga
Psyched: DEA's Denial Overruled, Fed Psychedelics Change, Psilocybin For Depression, States Reform & More
November 06, 2023
Tickers
ATAI
CMPS
CYBN
DEA
Tags
Penny Stocks
ATAI
PSIL
From
Benzinga
Single Dose Of Cybin's Psilocybin Shows Compelling Patient Outcomes, Phase 2 Results Find
November 01, 2023
Tickers
CYBN
Tags
Cannabis
Benzinga
CYBN
From
Benzinga
Psyched: Cybin's Center Stage In Novel Psychedelics, Musk & Ramaswamy, Britney's Memoirs And More
October 29, 2023
Tickers
ATAI
CMPS
CYBN
DMTTF
Tags
News
Financing
Rumors
From
Benzinga
Cybin's Deuterated Psychedelics Programs Protected By Three New International Patents
October 26, 2023
Tickers
CYBN
DMTTF
Tags
Market News
European Patent Office
United States Patent and Trademark Office (USPTO)
From
Benzinga
Cybin Officially Owns Small Pharma: Plans For New 'International Leader' In Psychedelic Therapeutics
October 23, 2023
Tickers
CYBN
DMTTF
Tags
Cannabis
Markets
Benzinga
From
Benzinga
Psyched: Jada Pinkett-Smith's Ayahuasca Journey, RIP Dr. Roland Griffiths, Congressional VA Hearings Halted
October 22, 2023
Tickers
ATAI
CMPS
CYBN
DMTTF
Tags
LSDI
News
Harvard University
From
Benzinga
Small Pharma's Q2 2024 Financial Highlights Ahead Of Cybin Merger For Global DMT Business
October 20, 2023
Tickers
CYBN
DMT
DMTTF
Tags
DMT
Penny Stocks
Psychedelics
From
Benzinga
Moving Closer To Cybin Acquisition, Small Pharma Obtains Final Order Approving Arrangement
October 18, 2023
Tickers
CYBN
DMTTF
Tags
Cannabis
Markets
CYBN
From
Benzinga
Psyched: FDA Warning, DEA's Telehealth Extension, CA Gov's Veto, Congress On Kratom, M&As & More
October 16, 2023
Tickers
ATAI
CMPS
CYBN
DMTTF
Tags
CYBN
Benzinga
MNMD
From
Benzinga
Cybin And Small Pharma Shareholders Green Light Acquisition Resolution: Results & Expected Dates
October 13, 2023
Tickers
CYBN
DMTTF
Tags
Contracts
Psychedelic/Assisted Therapies
Acquisitions
From
Benzinga
Psyched: Steve Cohen's New Biopharma Bet, California Gov. Authorizes Medical Psychedelics & More
October 06, 2023
Tickers
ATAI
BNOX
CMPS
CYBN
Tags
Cannabis
IXHL
CMPS
From
Benzinga
Cybin Completes Dosing In Phase 2 Study Of CYB003 For Major Depressive Disorder Treatment
October 03, 2023
Tickers
CYBN
Tags
major depressive disorder
News
Management
From
Benzinga
Steve Cohen Keeps Betting On Biopharma With Purchase Of 119M+ Bionomics Shares
October 03, 2023
Tickers
BNOX
CYBN
MRK
Tags
Psychedelics
BNOX
Penny Stocks
From
Benzinga
Psyched: DMT & SSRIs For Depression, MDMA Training, Negative Responses To Psychedelics & More
October 02, 2023
Tickers
ATAI
CMPS
CYBN
DMTTF
Tags
IXHL
Cannabis
CYBN
From
Benzinga
Cybin And Fluence Partner To Support EMBARK Training For Phase 3 CYB003 Trial For Depression
September 26, 2023
Tickers
CYBN
Tags
Markets
Psychedelic Therapists Training
Benzinga
From
Benzinga
< Previous
1
2
3
4
5
6
7
8
9
...
17
18
Next >
Stock Quote API & Stock News API supplied by
www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms Of Service
.